Dr. Jennifer Quizi

Dr. Quizi has a decade of experience in cancer therapy and serves as the Director of the Virus Manufacturing Facility at the Ottawa Hospital Research Institute. She leads the establishment of point-of-care manufacturing (POC) in Ottawa, focusing on the CliniMACS Prodigy system for the CLIC1901 clinical trial. Dr. Quizi also holds the position of Director, Biotherapeutics Manufacturing Operations at BioCanRx, overseeing POC manufacturing rollout across Canada and advocating for a unique training program called CanPRIME. She manages the POC cell manufacturing committee to ensure efficient and compliant POC manufacturing.